We now aspire to becoming the most significant health and life science research center in Europe, owing to a remarkable cluster of knowledge based 5,000 researchers, an excellent medical school, 11 university hospitals, and a thriving biotech business environment that already includes market leaders in diabetes and neuroscience. Until we embarked on governance reform, this would probably have been impossible.